Hand Eczema – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032
Hand eczema, or dermatitis, is frequently a persistent and complex condition. Its primary indications encompass dry, itchy skin that appears red or darker than the surrounding skin. Additional symptoms encompass skin fissures, soreness, and bleeding, with the potential development of blisters in certain instances. Typically, the skin becomes dry, scaly, and thickened, and during flare-ups, the fingers can become swollen, causing considerable discomfort. Hand eczema can hinder daily activities like buttoning clothes, writing, or using a computer in severe, long-lasting cases. Most hand eczema cases have multiple causative factors, broadly categorized as exogenous or endogenous. Among exogenous triggers, contact irritants, such as soaps, detergents, rubber, and various substances like vegetables, are often attributed to hand eczema. Physical friction and minor injuries can also lead to irritant contact dermatitis. Additionally, ingested allergens like nickel chromium and topically applied medications like neomycin and hydroxyquinolones can contribute to hand eczema. Dermatophytide reactions associated with tinea pedis can also affect the hands. Certain professions, including hairdressers, farmers, construction workers, dental and medical personnel, metalworkers, and food handlers, are prone to developing hand eczema. Various clinical patterns of hand eczema exist, primarily differing in clinical presentation rather than histology. These patterns include hyperkeratotic (resembling psoriasis or tylotic eczema), frictional, nummular, atopic, pompholyx (also known as dyshidrosis), and chronic vesicular hand dermatitis. Hybrid variations of these patterns are also observed, and there is some disagreement among experts regarding their classification. Clinically, hand eczema is characterized by observable signs such as redness, vesicles, papules, scaling, fissures, hyperkeratosis, and bothersome symptoms like itching and pain. "chronic hand eczema" applies when the condition persists for over six months. While diagnosing hand eczema may seem straightforward, it can occasionally be challenging to distinguish it from other dermatological conditions such as psoriasis, tinea mannum, lichen planus, pityriasis rubra pilaris, and palmar pustulosis. Treatment for hand eczema traditionally involves topical corticosteroids, oral antihistamines, emollients, and, in severe cases, short courses of systemic corticosteroids based on the disease's severity. Topical steroids are typically the first-line treatment for managing inflammation, with various types like desonide, mometasone furoate, clobetasol propionate, and betamethasone dipropionate, among others, being employed in hand eczema therapy.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment